Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: During the three and nine months ended February 29, 2012, TPL entered into licen
Reply New Message
Back To Forum List View

During the three and nine months ended February 29, 2012, TPL entered into licensing agreements with third parties, pursuant to which PDS recognized revenues of $2,452,000 and $3,009,300, respectively.

5 Recommendations
Re: During the three and nine months ended February 29, 2012, TPL entered into licen
1
cedarstreet
Apr 15, 2013 04:31PM
Re: During the three and nine months ended February 29, 2012, TPL entered into licen
2
stevens
Apr 15, 2013 04:32PM
Re: During the three and nine months ended February 29, 2012, TPL entered into licen
7
optymystic
Apr 15, 2013 04:52PM
Reply New Message
Back To Forum List View
Share
Share
New Message
Please login to post a reply